WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer Survivors

Not Applicable

Completed

Conditions: Breast Cancer
Fear of Cancer

Interventions: Other: Cognitive restructuring
Other: Telephone coaching
Other: Scheduled worry practice
Other: Diaphragmatic breathing and relaxation
Other: Usual care

First Posted Date: 2017-12-28

Last Posted Date: 2018-04-30

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 215

Registration Number: NCT03384992

EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic Surgery

Not Applicable

Completed

Conditions: Malignant Uterine Neoplasm
Uterine Neoplasm
Ovarian Carcinoma
Ovarian Neoplasm
Female Reproductive System Neoplasm
Malignant Female Reproductive System Neoplasm
Suspicious for Malignancy

Interventions: Other: Questionnaire Administration
Procedure: Supportive Care

First Posted Date: 2017-12-20

Last Posted Date: 2019-12-30

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 10

Registration Number: NCT03379376

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

A Mobile Intervention to Reduce Pain and Improve Health (MORPH)

Not Applicable

Completed

Conditions: Obesity
Chronic Pain
Sedentary Lifestyle

Interventions: Behavioral: MORPH

First Posted Date: 2017-12-19

Last Posted Date: 2021-01-22

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 33

Registration Number: NCT03377634

Locations: 🇺🇸
Wake Forest Baptist Medical Center Pain Center, Winston-Salem, North Carolina, United States

Apneic Oxygenation in the Pediatric Intensive Care Unit

Not Applicable

Completed

Conditions: Intubation Complication

Interventions: Procedure: Apneic Oxygenation

First Posted Date: 2017-12-15

Last Posted Date: 2024-10-04

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 41

Registration Number: NCT03374046

Locations: 🇺🇸
Advocate Lutheran General Hospital, Park Ridge, Illinois, United States

Topical Keratin in Treating Radiation Dermatitis in Patients With Breast Cancer

Not Applicable

Completed

Conditions: Breast Carcinoma
Radiation-Induced Dermatitis

Interventions: Other: Quality-of-Life Assessment
Other: Best Practice
Device: Topical Keratin

First Posted Date: 2017-12-15

Last Posted Date: 2024-06-11

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 25

Registration Number: NCT03374995

Locations: 🇺🇸
Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States

CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer

Phase 1

Withdrawn

Conditions: Stage IIIB Non-Small Cell Lung Cancer AJCC v7
Stage IV Non-Small Cell Lung Cancer AJCC v7

Interventions: Drug: 6,8-Bis(benzylthio)octanoic Acid
Drug: Docetaxel
Other: Pharmacological Study

First Posted Date: 2017-12-12

Last Posted Date: 2018-08-01

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT03370159

Locations: 🇺🇸
Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States

Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme

Phase 2

Terminated

Conditions: Glioblastoma
Glioblastoma Multiforme

Interventions: Drug: Disulfiram
Dietary Supplement: Copper gluconate
Drug: Temozolomide

First Posted Date: 2017-12-06

Last Posted Date: 2024-10-03

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 15

Registration Number: NCT03363659

Locations: 🇺🇸
Aurora Health Care, Aurora St. Luke's Medical Center, Milwaukee, Wisconsin, United States

LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple Myeloma

Phase 2

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Elotuzumab

First Posted Date: 2017-12-04

Last Posted Date: 2024-07-17

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 15

Registration Number: NCT03361306

Locations: 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States

Trauma Routing Algorithm for Pediatrics

Completed

Conditions: Pediatric All
Trauma

First Posted Date: 2017-12-02

Last Posted Date: 2021-12-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 4801

Registration Number: NCT03359421

Locations: 🇺🇸
Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States

Pre-medication With Alfentanil vs Placebo During ECT

Phase 4

Completed

Conditions: Blood Pressure
Electroconvulsive Therapy

Interventions: Drug: Placebos
Drug: Alfentanil

First Posted Date: 2017-12-02

Last Posted Date: 2021-07-08

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 100

Registration Number: NCT03359395

Locations: 🇺🇸
Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy